The Effect of the HEP Approach in Infants With Down Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Effect of the HEP Approach in Infants With Down Syndrome — Stella

Home/Down Syndrome (DS)/

View on ClinicalTrials.gov

Recruiting

Back to Down Syndrome (DS) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Turkey (Türkiye)

Sense On, Istanbul, Beykoz

Key details

Sponsor

Izgi Miray Demirbag

Enrollment target

~26 participants

Started

September 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

4 Months – 12 Months

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.